Travere Therapeutics
TVTX
TVTX
120 hedge funds and large institutions have $845M invested in Travere Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+7
Holders Change %
+6.19%
% of All Funds
2.73%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
17
Increased
40
Reduced
44
Closed
10
Calls
$16.1M
Puts
$1.45M
Net Calls
+$14.6M
Net Calls Change
+$2.98M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.26M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$2.93M |
| 3 |
D.E. Shaw & Co
New York
|
+$2.86M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.63M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.3M |
| 2 |
Jennison Associates
New York
|
-$9.12M |
| 3 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$5.22M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.33M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$3.35M |
